SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Stock Price, Quote, News and Overview
TSX-V:SVA - TSX Venture Exchange - CA81752F1062 - Common Stock - Currency: CAD
SVA.CA Quote, Performance and Key Statistics
TSX-V:SVA (7/21/2025, 7:00:00 PM)
0.17
0 (0%)
The current stock price of SVA.CA is 0.17 CAD. In the past month the price increased by 6.25%. In the past year, price decreased by -37.04%.
SVA.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 317.91M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 252.08M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 231.27M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 197.71M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 146.55M | ||
| WLLW.CA | WILLOW BIOSCIENCES INC | N/A | 125.89M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 75.64M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 19.69 | 70.20M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 66.70M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 58.20M | ||
| RVX.CA | RESVERLOGIX CORP | N/A | 44.07M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 29.5 | 41.47M |
Related stock screener links
About SVA.CA
Company Profile
Sernova Corp. is a clinical stage regenerative medicine company. The company is headquartered in London, Ontario. The firm is focused on developing and commercializing regenerative medicine therapeutics, including its Cell Pouch and associated technologies, including therapeutic cells and local cellular immune protection. The Cell Pouch is a scalable and implantable medical device. The Cell Pouch is designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of multiple chronic diseases, such as diabetes, hemophilia and thyroid disease. Its Cell Pouch combines with immune protected therapeutic cells, offers a protection from immune system attack. Its regenerative medicine therapeutic approach provides cell therapies, where the cells transplanted within an organ-like the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.
Company Info
SERNOVA BIOTHERAPEUTICS INC
700 Collip Circle, Ste 114
London ONTARIO N6G 4X8 CA
CEO: Philip M. Toleikis
Employees: 0
Phone: 15198585126.0
SERNOVA BIOTHERAPEUTICS INC / SVA.CA FAQ
What is the stock price of SERNOVA BIOTHERAPEUTICS INC today?
The current stock price of SVA.CA is 0.17 CAD.
What is the ticker symbol for SERNOVA BIOTHERAPEUTICS INC stock?
The exchange symbol of SERNOVA BIOTHERAPEUTICS INC is SVA and it is listed on the TSX Venture Exchange exchange.
On which exchange is SVA.CA stock listed?
SVA.CA stock is listed on the TSX Venture Exchange exchange.
What is SERNOVA BIOTHERAPEUTICS INC worth?
SERNOVA BIOTHERAPEUTICS INC (SVA.CA) has a market capitalization of 44.58M CAD. This makes SVA.CA a Nano Cap stock.
How many employees does SERNOVA BIOTHERAPEUTICS INC have?
SERNOVA BIOTHERAPEUTICS INC (SVA.CA) currently has 0 employees.
What are the support and resistance levels for SERNOVA BIOTHERAPEUTICS INC (SVA.CA) stock?
SERNOVA BIOTHERAPEUTICS INC (SVA.CA) has a support level at 0.17 and a resistance level at 0.19. Check the full technical report for a detailed analysis of SVA.CA support and resistance levels.
Should I buy SERNOVA BIOTHERAPEUTICS INC (SVA.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SVA.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SVA.CA, evaluating the profitability, health, valuation and growth aspects
- SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Sales and EPS estimates to see what analysts future expectations are.
- SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Stock Chart to make your own analysis
- SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Latest news and press-releases to stay up to date.
Does SERNOVA BIOTHERAPEUTICS INC (SVA.CA) stock pay dividends?
SVA.CA does not pay a dividend.
When does SERNOVA BIOTHERAPEUTICS INC (SVA.CA) report earnings?
SERNOVA BIOTHERAPEUTICS INC (SVA.CA) will report earnings on 2022-02-07.
SVA.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to SVA.CA. When comparing the yearly performance of all stocks, SVA.CA is a bad performer in the overall market: 92.08% of all stocks are doing better.
SVA.CA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
SVA.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to SVA.CA. The Buy consensus is the average rating of analysts ratings from 11 analysts.